Related Experiment Videos
Effect of transcription-factor concentrations on leukemic stem cells
Frank Rosenbauer1, Steffen Koschmieder, Ulrich Steidl
1Harvard Institutes of Medicine, 77 Avenue Louis Pasteur, Boston, MA 02115, USA.
Blood
|May 26, 2005
Summary
Leukemias are driven by leukemic stem cells, with reduced transcription factor activity potentially causing their formation in acute myeloid leukemia (AML). This suggests graded down-regulation, not complete loss, of these factors drives cancer development.
Area of Science:
- Hematology
- Molecular Biology
- Cancer Research
Background:
- Leukemias are sustained by leukemic stem cells.
- Molecular pathways for normal cell transformation into leukemic stem cells remain unclear.
- Key transcription factors are frequently mutated or down-regulated in acute myeloid leukemia (AML).
Purpose of the Study:
- To discuss the effects of transcription factor concentrations on hematopoiesis and leukemia.
- To focus on the regulation of transcription factor gene expression in blood development and cancer.
Main Methods:
- Review of existing evidence on transcription factors in AML.
- Analysis of findings from mouse models with hypomorphic transcription-factor genes.
- Examination of patient data regarding transcription factor gene mutations and deletions.
Main Results:
- Reduced transcription factor activity below a critical threshold can cause leukemic stem cell formation in AML.
- AML is generally associated with graded down-regulation rather than complete disruption of transcription factors.
- Transcription factor gene expression regulation is a key mechanism altering critical threshold levels.
Conclusions:
- Transcription factor concentration is critical for normal hematopoiesis and leukemia development.
- Understanding transcription factor regulation offers insights into AML pathogenesis.
- Targeting transcription factor gene expression may present therapeutic strategies for AML.